CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

YogaWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (6)

Name (Synonyms) Correlation
drug398 Best available care Wiki 0.58
drug2920 Tigerase® and best available care Wiki 0.58
drug1701 Media Intervention Wiki 0.58
drug1709 Meditation Therapy Wiki 0.58
drug2302 Quality-of-Life Assessment Wiki 0.33
drug2312 Questionnaire Administration Wiki 0.22

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D053120 Respiratory Aspiration NIH 0.18
D003863 Depression, NIH 0.08
D018352 Coronavirus Infections NIH 0.02

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There are 3 clinical trials

Clinical Trials

1 Tools for Wellbeing COVID-19 National Study of Undergraduate Students

The study evaluates the effectiveness of yoga practices on reducing stress, negative emotion, anxiety, and depression and on increasing positive emotion, wellbeing and resilience. The study uses randomized wait-list control. All U.S. undergraduate students in 4-year universities and colleges age 18 or older are eligible to participate.

NCT04414371 Stress Anxiety Depression Resilience Wellbeing Mood Other: Yoga
MeSH:Depression

Primary Outcomes

Description: 10-item Perceived Stress Scale (PSS), score 0-40, higher the score, higher stress

Measure: Stress

Time: Change from baseline stress at 1-Month

Description: 10-item Perceived Stress Scale (PSS), score 0-40, higher the score, higher stress

Measure: Stress

Time: Change from baseline stress at 2-Month

Description: 10-item Perceived Stress Scale (PSS), score 0-40, higher the score, higher stress

Measure: Stress

Time: Change from baseline stress in 3-Month

Description: 14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

Measure: Wellbeing

Time: Change from baseline wellbeing in 2-week

Description: 14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

Measure: Wellbeing

Time: Change from baseline wellbeing in 4-week

Description: 14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

Measure: Wellbeing

Time: Change from baseline wellbeing in 6-week

Description: 14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

Measure: Wellbeing

Time: Change from baseline wellbeing in 8-week

Description: 14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

Measure: Wellbeing

Time: Change from baseline wellbeing in 10-week

Description: 14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

Measure: Wellbeing

Time: Change from baseline wellbeing in 12-week

Secondary Outcomes

Description: 2-item PHQ-4, score 2-8, higher score higher anxiety

Measure: Anxiety

Time: Change from baseline anxiety in 2-week

Description: 2-item PHQ-4, score 2-8, higher score higher anxiety

Measure: Anxiety

Time: Change from baseline anxiety in 4-week

Description: 2-item PHQ-4, score 2-8, higher score higher anxiety

Measure: Anxiety

Time: Change from baseline anxiety in 6-week

Description: 2-item PHQ-4, score 2-8, higher score higher anxiety

Measure: Anxiety

Time: Change from baseline anxiety in 8-week

Description: 2-item PHQ-4, score 2-8, higher score higher anxiety

Measure: Anxiety

Time: Change from baseline anxiety in 10-week

Description: 2-item PHQ-4, score 2-8, higher score higher anxiety

Measure: Anxiety

Time: Change from baseline anxiety in 12-week

Description: 2-item PHQ-4, score 2-8, higher score higher depression

Measure: Depression

Time: Change from baseline depression in 2-week

Description: 2-item PHQ-4, score 2-8, higher score higher depression

Measure: Depression

Time: Change from baseline depression in 4-week

Description: 2-item PHQ-4, score 2-8, higher score higher depression

Measure: Depression

Time: Change from baseline depression in 6-week

Description: 2-item PHQ-4, score 2-8, higher score higher depression

Measure: Depression

Time: Change from baseline depression in 8-week

Description: 2-item PHQ-4, score 2-8, higher score higher depression

Measure: Depression

Time: Change from baseline depression in 10-week

Description: 2-item PHQ-4, score 2-8, higher score higher depression

Measure: Depression

Time: Change from baseline depression in 12-week

Description: 6-item Brief Resilience Scale (BRS), score 6-30, higher score higher resilience

Measure: Resilience

Time: Change from baseline resilience in 1-month

Description: 6-item Brief Resilience Scale (BRS), score 6-30, higher score higher resilience

Measure: Resilience

Time: Change from baseline resilience in 2-month

Description: 6-item Brief Resilience Scale (BRS), score 6-30, higher score higher resilience

Measure: Resilience

Time: Change from baseline resilience in 3-month

Description: 10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

Measure: Positive Affect

Time: Change from baseline positive affect in 2-week

Description: 10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

Measure: Positive Affect

Time: Change from baseline positive affect in 4-week

Description: 10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

Measure: Positive Affect

Time: Change from baseline positive affect in 6-week

Description: 10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

Measure: Positive Affect

Time: Change from baseline positive affect in 8-week

Description: 10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

Measure: Positive Affect

Time: Change from baseline positive affect in 10-week

Description: 10-item Positive Affect Scale, score - 10 to 50, higher score higher positive affect

Measure: Positive Affect

Time: Change from baseline positive affect in 12-week

Description: 10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

Measure: Negative Affect

Time: Change from baseline negative affect in 2-week

Description: 10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

Measure: Negative Affect

Time: Change from baseline negative affect in 4-week

Description: 10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

Measure: Negative Affect

Time: Change from baseline negative affect in 6-week

Description: 10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

Measure: Negative Affect

Time: Change from baseline negative affect in 8-week

Description: 10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

Measure: Negative Affect

Time: Change from baseline negative affect in 10-week

Description: 10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

Measure: Negative Affect

Time: Change from baseline negative affect in 12-week

2 Effect of Breathing-based Meditation (Sudarshan Kriya Yoga) in NHS Health Care Workers With Possible COVID-19 Related Stress and Anxiety Disorder

Recent reports have highlighted Covid-19 related increase in levels of depression and stress related disorders in the health care professionals. Pranayama (ancient yogic breathing techniques) helps harmonizing breathing by regular voluntary control of breath. Yoga has been shown to modulate autonomic nervous functions of the brain. Sudarshan kriya Yoga (SKY) is a unique form of pranayama taught by ''Art of Living UK'' a non-profit organization -for over two decades. SKY involves simple rhythmic breathing technique (easy to practice) that aims at harmonizing body, mind and emotions. Sudarshan kriya yoga (SKY) has been shown to be beneficial in reducing levels of stress, anxiety and depression. This breathing based meditation technique has previously been shown to be beneficial in post-traumatic stress disorder. In this pilot study the aim is to assess the feasibility and effect of SKY in NHS health care workers with possible Covid-19 related stress and anxiety disorder.

NCT04481516 Stress Other: Yoga

Primary Outcomes

Description: (1) To assess feasibility and efficacy of regularly supervised SKY in the NHS health care workers with possible Covid-19 related stress and anxiety disorder in the short term (6 weeks) by using Generalised Anxiety Disorder questionnaire score ranging from 0-21, higher score associated with worse outcome

Measure: Alleviated stress 1 - short term

Time: 6 weeks

Description: (2) To assess feasibility and efficacy of regularly supervised SKY in the NHS health care workers with possible Covid-19 related stress and anxiety disorder in the short term (6 weeks) by using Medical Outcomes Study Questionnaire Short Form 36 Health Survey questionnaire score ranging from 36-149, higher score associated with worse outcome

Measure: Alleviated stress 2 - short term

Time: 6 weeks

Description: (3) To assess feasibility and efficacy of regularly supervised SKY in the NHS health care workers with possible Covid-19 related stress and anxiety disorder in the short term (6 weeks) by using Patient Health Questionnaire questionnaire score ranging from 0-27, higher score associated with worse outcome

Measure: Alleviated stress 3 - short term

Time: 6 weeks

Secondary Outcomes

Description: (1) To assess feasibility and efficacy of regularly supervised SKY in the NHS health care workers with possible Covid-19 related stress and anxiety disorder in the short term (6 weeks) by using Generalised Anxiety Disorder questionnaire score ranging from 0-21, higher score associated with worse outcome

Measure: Alleviated stress 1 - medium term

Time: 3-6 months

Description: (2) To assess feasibility and efficacy of regularly supervised SKY in the NHS health care workers with possible Covid-19 related stress and anxiety disorder in the short term (6 weeks) by using Medical Outcomes Study Questionnaire Short Form 36 Health Survey questionnaire score ranging from 36-149, higher score associated with worse outcome

Measure: Alleviated stress 2 - medium term

Time: 3-6 months

Description: (3) To assess feasibility and efficacy of regularly supervised SKY in the NHS health care workers with possible Covid-19 related stress and anxiety disorder in the short term (6 weeks) by using Patient Health Questionnaire questionnaire score ranging from 0-27, higher score associated with worse outcome

Measure: Alleviated stress 3 - medium term

Time: 3-6 months

3 Breathing Techniques and Meditation for Health Care Workers During COVID-19

This phase I trial investigates breathing techniques and meditation for health care workers during COVID-19 pandemic. Breathing techniques and medication may help manage stress and improve lung health. The goal of this trial is to learn if breathing techniques and meditation may help to reduce stress and improve lung health in health care workers during the COVID-19 pandemic.

NCT04482647 COVID-19 Infection Other: Media Intervention Procedure: Meditation Therapy Other: Quality-of-Life Assessment Other: Questionnaire Administration Procedure: Yoga
MeSH:Respiratory Aspiration

Primary Outcomes

Description: Feasibility will be defined as recruitment of 50 participants to the study within 2 months.

Measure: Study recruitment

Time: Within 2 months

Description: Defined as more than 50% of participants perceive the intervention as useful.

Measure: Acceptability of study

Time: Up to 2 years

Secondary Outcomes

Description: Will determine the adherence to the practice assessed as at least 50% of participants implement the intervention for 3 or more times in a week by the end of week 1/day 7 (+ 3 days).

Measure: Adherence to the practice

Time: Up to 28 days

Description: Measured by the Brief Resilient Coping Scale among health care workers questionnaire.

Measure: Change in resilience

Time: Day 0 to 28

Description: Measured by the Perceived Stress Scale and COVID-19 Stress among health care workers questionnaire.

Measure: Perceive stress and psychological impact

Time: Day 0 to 28

Description: Will determine the differences in breath holding time between those who are adherent and those who are not adherent to the practice.

Measure: Breath holding time

Time: Up to 28 days

Other Outcomes

Description: Will be assessed by self-reported spirometric evaluation measuring FEV1 and FVC.

Measure: Forced expiratory volume in 1 minute (FEV1) and forced vital capacity (FVC)

Time: Up to 28 days

No related HPO nodes (Using clinical trials)